Navigation Links
New Report Just Published: World Multiple Myeloma Therapeutics Market Report
Date:7/7/2009

Syndromes II-32 Hematological Cancer Therapies II-33 Chemotherapy II-33 Radiation Therapy II-33 Stem Cell Transplants II-33 Biological Therapy II-34 Targeted Therapy II-34 Gene Therapy II-34 Immunotherapy II-34 Monoclonal Antibody Treatment II-35 Vaccines II-35 Donor Lymphocyte Infusion II-35 Hematological Cancer Drug Classes II-35 Hypomethylating Agents & Antimetabolites II-35 Bisphosphonates II-36 Alkylating Agents and DNA-Damaging Agents II-36 DNA-Repair Enzyme Inhibitors II-36 Histone Deacetylase Inhibitor II-36 Immunomodulators II-36 Proteasome Inhibitor II-36 Tyrosine Kinase Inhibitors II-36 3. Clinical Trials and Drug Approvals II-37 NICE Grants Approval for Use of Revlimid(R) II-37 SWOG Announces Closure of Phase III Trial (S0232) for Patients with Multiple Myeloma II-37 Fujimoto Pharmaceutical Receives Approval to Market Thalidomide II-37 Celgene Obtains Health Canada Approval for Revlimid Oral Cancer Drug II-37 FDA Grants Orphan-Drug Designation to Melphalan II-38 Merck Commences Phase II-b and Phase III Clinical Trial of Zolinza II-38 Clavis Initiates Phase II Trial of Elacytarabine II-38 Gilead Sciences Commences GS 9219 Phase I Clinical Trial II-38 AstraZeneca Carries Out AZD 0530 Phase II trial II-39 European Commission Grants Approval of Thalidomide for Multiple Myeloma II-39 EMEA Issues Positive Opinion for Thalidomide Use in Multiple Myeloma II-39 Global Regulatory Developments for the Use of Revlimid(R) in Multiple Myeloma II-39 Takeda Gains FDA Approval to Promote Velcade II-40 Health Canada Approves VELCADE II-40 Genzyme Receives FDA Certification for Mozobil II-40 Celgene's Thalidomide Pharmion Receives Marketing Authorization II-41 Ziopharm Commences Phase II Clinical Trial of ZIO-101 II-41 FDA Approves Pluristem's P
'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Virginia Tech Report Has National Importance
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
4. Haemacure Reports Third Quarter 2007 Results
5. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
6. Biotech Finishes on a High in August, Burrill Report Says
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. First New York/New Jersey Health Care Report Card Released
11. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... WEDNESDAY, Sept. 17, 2014 (HealthDay News) -- Present-day ... groups of ancient humans, according to a new ... descended from indigenous hunter-gatherers and early European farmers. ... samples revealed they are also the descendants of ... genetic material from this third ancestral group, researchers ...
(Date:9/17/2014)... Dennis Thompson HealthDay Reporter ... Diabetics and dieters who turn to artificial sweeteners to ... any favors, a new Israeli study suggests. Artificial ... containing no calories, researchers found in human and mouse ... to alter the bacteria residing in the intestines in ...
(Date:9/17/2014)... Research has shown that most 18-month-olds learn an ... however, little is known about how children process information ... preschool years. In a new study, a University of ... as they age, and a limit exists as to ... findings could help parents enhance their children,s vocabularies and ...
(Date:9/17/2014)... In a country where 77% of ... regular basis, how can Americans find healthy and fulfilling ... Stress Challenge , a 5-day interactive journey to putting ... From September 29th – October 3rd, the Hyland’s ... to specific topics that promote natural solutions for managing ...
(Date:9/17/2014)... Doheny HealthDay Reporter WEDNESDAY, ... beverage companies have made good on their pledge to cut ... The companies, acting together through the Healthy Weight Commitment Foundation, ... 2007 and 2012 and 1.5 trillion by 2015. They,ve actually ... collectively met their pledge and exceeded their pledge," said lead ...
Breaking Medicine News(10 mins):Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 3Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 2Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 3Health News:Babies learn words differently as they age, researcher finds 2Health News:Stress Less with the Hyland's 5-Day Stress Challenge 2Health News:Major U.S. Food Makers Cut 6.4 Trillion Calories From Products: Report 2Health News:Major U.S. Food Makers Cut 6.4 Trillion Calories From Products: Report 3
... in patients aged 80 and older, researchers say , ... questions the widespread use of implantable cardiac devices in ... in the hospital after receiving the devices. , Patients ... implantable defibrillators and pacemakers, even though most clinical trials ...
... no longer safe on the road , MONDAY, April ... input from family members are the most useful tools in ... or other dementia sets in, according to new guidelines from ... assessments are usually more accurate than the patient,s own opinion ...
... expert says , MONDAY, April 12 (HealthDay News) -- A ... in the blood raises the risk of heart disease for ... however, is not seen in men, according to the report, ... . , The study, by researchers at Italy,s National Cancer ...
... Important advances in the fight against cancer have come as ... were previously unknown to scientists. A new study led ... activate a viral infection that, paradoxically, can help anti-viral medications ... a team of UNC School of Medicine scientists and the ...
... In an ongoing effort to scientifically validate the age-old belief ... of patients, The University of Texas M. D. Anderson Cancer ... the efficacy of incorporating yoga into the treatment program of ... ever awarded by the National Cancer Institute for the study ...
... pain can go on too long and be ineffective, study ... that many patients with terminal cancer don,t benefit from getting ... symptoms like pain. , The researchers, who reported their findings ... Cancer , say doctors are failing to properly adjust treatments ...
Cached Medicine News:Health News:Study Questions Use of Heart Device Implants in the Very Old 2Health News:Docs Issue Guidelines for Drivers With Dementia 2Health News:Docs Issue Guidelines for Drivers With Dementia 3Health News:Simple Carbs Pose Heart Risk for Women 2Health News:Simple Carbs Pose Heart Risk for Women 3Health News:UNC study offers first clinical evidence of anti-cancer drug triggering viral infection 2Health News:M. D. Anderson receives 4.5 million grant, largest ever for study of yoga and cancer 2Health News:Many Terminal Cancer Patients May Be Overtreated 2
(Date:9/17/2014)... N.J. , Sept. 17, 2014  Bayer HealthCare ... National Hemophilia Foundation,s 66 th Annual Meeting, which ... , D.C.  The data, which will be shared through ... treatment and patient care. Data will be presented in ... research into treatment modalities in hemophilia A patients, Bayer ...
(Date:9/17/2014)... , September 17, 2014 According ... by Component (Sensor, Battery, Memory Device, Display, & Microprocessor/MCU), ... & Wellness), and by Geography - Global Forecast to ... electronics market is expected to reach $56.50 Billion by ... to 2020. Browse 235 market data Tables ...
(Date:9/17/2014)... CITY, Utah , Sept. 17, 2014 /PRNewswire/ ... an exclusive global licensing and collaboration agreement with ... and commercialize NuView,s investigative genomic-based diagnostic biomarker to ... agreement also includes all other future diagnostic-imaging applications. ... for in-vivo therapeutic delivery and in-vitro urine screen ...
Breaking Medicine Technology:Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 2Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 4Medical Electronics Market Worth $56.50 Billion by 2020 2Medical Electronics Market Worth $56.50 Billion by 2020 3Medical Electronics Market Worth $56.50 Billion by 2020 4NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 2NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 3NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 4NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 5
... WORCESTER, Mass. and TORONTO, May 17, 2012  Generex ... today that new members have joined the Scientific ... Express, Inc. for the company,s AE37 breast cancer ... N. Hortobagyi, MD, FACP (University of Texas MD ...
... TUCSON, Ariz., May 17, 2012 SynCardia Systems, Inc. ... only FDA, Health Canada and CE (Europe) approved Total ... March 31, 2012, due in part to Certified Centers ... SynCardia temporary Total Artificial Heart . ...
Cached Medicine Technology:Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine 2Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine 3Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine 4SynCardia Posts Record Revenue and Profit in Q1 2012 2SynCardia Posts Record Revenue and Profit in Q1 2012 3
High sensitive, specific one step immunochromatographic assay for human infectious disease...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Detection of Malarial antigen in Human whole blood....
The KAT-Quick Malaria test was designed for the diagnosis of Malaria, in laboratories, the home and for medical kits when travelling into malaria regions....
Medicine Products: